Home | Business News | Browse by Publication | P | PR Newswire

FDA Approves New Post-Heart Attack Treatment.

Publication: PR Newswire
Publication Date: 03-AUG-05
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Popular blood pressure medication is now approved to treat patients after a heart attack.

EAST HANOVER, N.J., Aug. 3 /PRNewswire-FirstCall/ --

FORMAT: VNR, nat sound pass, loose b-roll, extra bites. BACKGROUND: The FDA has just approved Diovan(R) (valsartan) to reduce cardiovascular death in patients at high risk following a heart attack. More than ONE MILLION Americans suffer a heart attack annually. One third of those patients will die within a year of their first attack. INTERVIEW: -- Marc Pfeffer, Lead Investigator of...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
NYSE Closing Wednesday, Aug. 3, 2005., August 03, 2005
Par Pharmaceutical Receives Final Approval to Market Clonazepam Orally..., August 03, 2005
Emergency Medical Services L.P. Posts Quarterly Earnings., August 03, 2005
TSA Federal Security Director at Indianapolis Airport in Fatal Acciden..., August 03, 2005
ATP Oil & Gas Corporation Expands Offering and Closes $175 Million Pri..., August 03, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.